| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | SELL | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 0.46▲ | 0.46▲ | 0.46▲ | 0.47▲ | 0.39▲ |
| MA10 | 0.47▲ | 0.47▼ | 0.47▼ | 0.43▲ | 0.53▼ |
| MA20 | 0.48▼ | 0.47▼ | 0.47▲ | 0.38▲ | 0.67▼ |
| MA50 | 0.45▲ | 0.43▲ | 0.41▲ | 0.54▼ | 1.13▼ |
| MA100 | 0.40▲ | 0.37▲ | 0.39▲ | 0.71▼ | 1.31▼ |
| MA200 | 0.36▲ | 0.48▼ | 0.53▼ | 1.07▼ | 2.77▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.006▼ | -0.006▼ | -0.006▼ | 0.026▲ | -0.006▼ |
| RSI | 51.662▲ | 54.188▲ | 55.413▲ | 54.001▲ | 31.136▼ |
| STOCH | 18.174▼ | 14.167▼ | 14.167▼ | 82.198▲ | 21.787 |
| WILL %R | -56.342 | -56.342 | -56.342 | -15.983▲ | -61.171 |
| CCI | -23.921 | -20.817 | -25.212 | 80.821 | -56.693 |
|
Thursday, May 01, 2025 05:00 PM
BELTSVILLE, Md., May 01, 2025 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class, and ...
|
|
Tuesday, April 29, 2025 02:45 PM
In the most recent trading session, Nextracker (NXT) closed at $43.07, indicating a -0.3% shift from the previous trading day.
|
|
Tuesday, April 29, 2025 01:25 PM
Phase 1a dose-escalation study data update: treatment with NXP900 resulted in exposure levels leading to robust pharmacodynamic responses across a range of tolerated doses; NXP900 has an acceptable ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 01/05/25 | 0.4422 | 0.4782 | 0.4422 | 0.4718 | 40,169 |
| 30/04/25 | 0.51 | 0.51 | 0.4561 | 0.4654 | 245,219 |
| 29/04/25 | 0.4649 | 0.50 | 0.4649 | 0.4836 | 168,402 |
| 28/04/25 | 0.489 | 0.489 | 0.442 | 0.465 | 193,800 |
| 25/04/25 | 0.43 | 0.499 | 0.395 | 0.46 | 321,800 |
| 24/04/25 | 0.415 | 0.439 | 0.38 | 0.419 | 131,200 |
| 23/04/25 | 0.429 | 0.429 | 0.401 | 0.4201 | 210,757 |
| 22/04/25 | 0.40 | 0.412 | 0.375 | 0.401 | 376,100 |
| 21/04/25 | 0.3598 | 0.3949 | 0.3597 | 0.369 | 239,717 |
| 17/04/25 | 0.339 | 0.365 | 0.321 | 0.361 | 236,500 |
|
|
||||
|
|
||||
|
|